Evidence map›Paper›PMID 42604043›Full record

ArticleRadiology case reports2026

Infraorbital myxofibrosarcoma: Imaging features and surgical management of a rare facial case.

Jihad Afakire, Mohammed El Magroud, Amal Bennani, Zainab El Zouiti, Adil Eabdenbi Tsen

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jihad AfakireFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Mohammed El MagroudFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Amal BennaniFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Zainab El ZouitiFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Adil Eabdenbi TsenFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxofibrosarcoma is a rare malignant soft tissue sarcoma, typically arising in the extremities of elderly patients and exceptionally involving the head and neck region. Infraorbital localization is particularly uncommon and poses a diagnostic challenge due to the complex anatomy of the midface and the broad differential diagnosis in this region. We report the case of a 50-year-old man with a progressively enlarging, painless left infraorbital mass over 3 months. Contrast-enhanced maxillofacial computed tomography revealed a heterogeneous soft-tissue lesion with peripheral enhancement, central necrosis, subtle infiltration of adjacent fat planes, and smooth scalloping of the anterior maxillary sinus wall without cortical destruction. These findings raised suspicion of malignancy despite the relatively well-circumscribed appearance of the lesion. The patient underwent complete surgical excision with negative margins and reconstruction using a Mustardé cheek rotation flap. Histopathology confirmed a high-grade myxofibrosarcoma. Postoperative adjuvant radiotherapy was administered. At 6-month follow-up, no recurrence was observed. This case highlights an important radiological teaching point: smooth bone scalloping without cortical destruction does not exclude malignancy. Subtle imaging features such as necrosis, heterogeneous enhancement, and infiltration of adjacent fat planes may represent critical clues to aggressive behavior and should prompt careful evaluation.

Indexed as

Case reportComputed tomographyInfraorbital regionMyxofibrosarcomaSurgical excision

Identifiers

PMID42604043
PMCPMC13476687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.